Skip to main content
Erschienen in: Inflammation Research 9/2020

11.06.2020 | Original Research Article

The association between IL18, FOXP3 and IL13 genes polymorphisms and risk of allergic rhinitis: a meta-analysis

verfasst von: Liang Tang, Yongjun Chen, Qin Xiang, Ju Xiang, Yonghong Tang, Jianming Li

Erschienen in: Inflammation Research | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Allergic rhinitis (AR) is a chronic inflammatory disease of nasal mucosa. Loss of function of Th17 cells and regulatory T (Treg) cells plays a role in the pathogenesis of AR. IL18, FOXP3, and IL13 are key genes in the development of AR. However, the genetic associations between IL18, FOXP3 and IL13 genes polymorphisms and AR risk were inconclusive yet.

Methods

A meta-analysis was performed by searching through Pubmed, EMBASE, web of science and CNKI databases. The ORs and 95%CIs were used to assess the genetic association between the allelic, dominant and recessive models of IL18, FOXP3 and IL13 genes polymorphisms and AR risk.

Results

A total of 15 articles (6 for FOXP3, 5 for IL18, and 5 for IL13) were enrolled in the present study. No association was detected between the IL18 rs187238, rs1946518, rs360721, FOXP3 rs2232365, rs3761548 and IL13 rs1800925 polymorphisms and AR risk (p > 0.05). Significant associations were observed between the allelic (p = 0.001, OR 1.32, 95% CI 1.12–1.56), dominant (p = 0.005, OR 1.43, 95% CI 1.11–1.83) and recessive models (p = 0.01, OR 1.64, 95% CI 1.13, 2.40) of IL13 rs20541 and AR risk. Subgroup analysis based on ethnicity revealed that the IL13 rs20541 was significantly associated with AR risk in Asian population (allelic model: p = 0.009, OR 1.36, 95% CI 1.13–1.63, dominant model: p = 0.005, OR 1.43, 95% CI 1.11–1.83; recessive model: p = 0.01, OR 1.64, 95% CI 1.13–2.40).

Conclusions

IL13 rs20541 may contribute to the risk of AR in Asian population. To confirm these results, larger number of case–control study with more subjects is necessary in the future.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Plaut M, Valentine MD. Allergic Rhinitis. N Engl J Med. 2005;353:1934–44.PubMed Plaut M, Valentine MD. Allergic Rhinitis. N Engl J Med. 2005;353:1934–44.PubMed
2.
Zurück zum Zitat Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol allergy Clin N Am. 2016;36(2):261–78. Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol allergy Clin N Am. 2016;36(2):261–78.
3.
Zurück zum Zitat May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39(12):2410–9.PubMed May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39(12):2410–9.PubMed
4.
Zurück zum Zitat Sinha B, Vibha X, Singla R, Chowdhury R. Allergic rhinitis: a neglected disease—a community based assessment among adults in Delhi. J Postgrad Med. 2015;61(3):169–75.PubMedPubMedCentral Sinha B, Vibha X, Singla R, Chowdhury R. Allergic rhinitis: a neglected disease—a community based assessment among adults in Delhi. J Postgrad Med. 2015;61(3):169–75.PubMedPubMedCentral
5.
Zurück zum Zitat Dunlop J, Matsui E, Sharma HP. Allergic rhinitis: environmental determinants. Immunol Allergy Clin N Am. 2016;36(2):367–77. Dunlop J, Matsui E, Sharma HP. Allergic rhinitis: environmental determinants. Immunol Allergy Clin N Am. 2016;36(2):367–77.
6.
Zurück zum Zitat Lee JH, Koh SH. Genetic role in allergic rhinitis. J Rhinol. 2010;17(1):7–12. Lee JH, Koh SH. Genetic role in allergic rhinitis. J Rhinol. 2010;17(1):7–12.
7.
Zurück zum Zitat Gu ZW, Wang YX, Cao ZW. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model. Oncotarget. 2017;8(9):14314–24.PubMedPubMedCentral Gu ZW, Wang YX, Cao ZW. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model. Oncotarget. 2017;8(9):14314–24.PubMedPubMedCentral
8.
Zurück zum Zitat Xiao C, Li H, Li H, Cheng Z, Qin J, Zhou W, et al. The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum. J Clin Otorhinolaryngol. 2010;24(20):924–7. Xiao C, Li H, Li H, Cheng Z, Qin J, Zhou W, et al. The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum. J Clin Otorhinolaryngol. 2010;24(20):924–7.
9.
Zurück zum Zitat Yu SQ. Content of CD4+CD25+ regulatory T cells in peripheral blood lymphocytes in patients with allergic rhinitis. J Clin Otorhinolaryngol Head Neck Surg. 2011;25(8):354–9. Yu SQ. Content of CD4+CD25+ regulatory T cells in peripheral blood lymphocytes in patients with allergic rhinitis. J Clin Otorhinolaryngol Head Neck Surg. 2011;25(8):354–9.
10.
Zurück zum Zitat Larsson K, Lindstedt M, Lundberg K, Dexlin L, Wingren C, Korsgren M, et al. CD4+ T cells have a key instructive role in educating dendritic cells in allergy. Int Arch Allergy Immunol. 2009;149(1):1–15.PubMed Larsson K, Lindstedt M, Lundberg K, Dexlin L, Wingren C, Korsgren M, et al. CD4+ T cells have a key instructive role in educating dendritic cells in allergy. Int Arch Allergy Immunol. 2009;149(1):1–15.PubMed
11.
Zurück zum Zitat Liu Y, Zeng M, Liu Z. Clinical relevance of Th17 response in allergic rhinitis: more evidence. Clin Exp Allergy. 2015;45(12):1875.PubMed Liu Y, Zeng M, Liu Z. Clinical relevance of Th17 response in allergic rhinitis: more evidence. Clin Exp Allergy. 2015;45(12):1875.PubMed
12.
Zurück zum Zitat Ciprandi G, Filaci G, Fenoglio D. Th17 cells and allergic rhinitis: is there clinical relevance? Otolaryngol Head Neck Surg. 2010;143(4):604–5.PubMed Ciprandi G, Filaci G, Fenoglio D. Th17 cells and allergic rhinitis: is there clinical relevance? Otolaryngol Head Neck Surg. 2010;143(4):604–5.PubMed
13.
Zurück zum Zitat Lee SM, Gao BX, Dahl M, Calhoun K, Fang D. Decreased FOXP3 gene expression in the nasal secretions from patients with allergic rhinitis. Otolaryngol Head Neck Surg. 2009;140(2):197–201.PubMed Lee SM, Gao BX, Dahl M, Calhoun K, Fang D. Decreased FOXP3 gene expression in the nasal secretions from patients with allergic rhinitis. Otolaryngol Head Neck Surg. 2009;140(2):197–201.PubMed
14.
Zurück zum Zitat Zhang L, Zhang Y, Desrosiers M, Wang C, Zhao Y, Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Human Immunol. 2009;70(11):934. Zhang L, Zhang Y, Desrosiers M, Wang C, Zhao Y, Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Human Immunol. 2009;70(11):934.
15.
Zurück zum Zitat Fodor E, Garaczi E, Hilda P, et al. The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Human Immunol. 2011;72(10):930–4. Fodor E, Garaczi E, Hilda P, et al. The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Human Immunol. 2011;72(10):930–4.
16.
Zurück zum Zitat Zhang Y, Duan S, Wei X, Zhao Y, Zhao L, Zhang L. Association between polymorphisms in FOXP3 and EBI3 genes and the risk for development of allergic rhinitis in Chinese subjects. Hum Immunol. 2012;73(9):939–45.PubMed Zhang Y, Duan S, Wei X, Zhao Y, Zhao L, Zhang L. Association between polymorphisms in FOXP3 and EBI3 genes and the risk for development of allergic rhinitis in Chinese subjects. Hum Immunol. 2012;73(9):939–45.PubMed
17.
Zurück zum Zitat Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern Med Rev. 2001;6(1):20–47.PubMed Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern Med Rev. 2001;6(1):20–47.PubMed
18.
Zurück zum Zitat Huebner M, Kim DY, Ewart S, Karmaus W, Sadeghnejad A, Arshad SH. Patterns of GATA3 and IL13 gene polymorphisms associated with childhood rhinitis and atopy in a birth cohort. J Allergy Clin Immunol. 2008;121(2):408–14.PubMed Huebner M, Kim DY, Ewart S, Karmaus W, Sadeghnejad A, Arshad SH. Patterns of GATA3 and IL13 gene polymorphisms associated with childhood rhinitis and atopy in a birth cohort. J Allergy Clin Immunol. 2008;121(2):408–14.PubMed
19.
Zurück zum Zitat Llanes E, Quiralte J, López E. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int Arch Allergy Immunol. 2009;148(3):228–38.PubMed Llanes E, Quiralte J, López E. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int Arch Allergy Immunol. 2009;148(3):228–38.PubMed
20.
Zurück zum Zitat Wang M, Xing ZM, Lu C, Ma YX, Yu DL, Yan Z. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet. 2003;113(5):387–90.PubMed Wang M, Xing ZM, Lu C, Ma YX, Yu DL, Yan Z. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet. 2003;113(5):387–90.PubMed
21.
Zurück zum Zitat Bottema RWB, Nolte IM, Howard TD. Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol. 2010;153(3):259–67.PubMed Bottema RWB, Nolte IM, Howard TD. Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol. 2010;153(3):259–67.PubMed
22.
Zurück zum Zitat Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol. 2001;125(2):177–83.PubMedPubMedCentral Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol. 2001;125(2):177–83.PubMedPubMedCentral
23.
Zurück zum Zitat Sebelova S, Izakovicova-Holla L, Stejskalova A, Schüller M, Znojil V, Vasku A. Interleukin-18 and its three gene polymorphisms relating to allergic rhinitis. J Hum Genet. 2007;52(2):152–8.PubMed Sebelova S, Izakovicova-Holla L, Stejskalova A, Schüller M, Znojil V, Vasku A. Interleukin-18 and its three gene polymorphisms relating to allergic rhinitis. J Hum Genet. 2007;52(2):152–8.PubMed
24.
Zurück zum Zitat Tungtrongchitr A, Jumpasri J, Sookrung N, Visitsunthorn N, Tantilipikorn P, Piboonpocanan O, et al. Alteration of -656(G/T) and -607(C/A) polymorphisms in interleukin-18 (IL-18) gene in house dust mite-sensitive allergic rhinitis patients in Thailand. Genet Mol Res. 2017;16:3. Tungtrongchitr A, Jumpasri J, Sookrung N, Visitsunthorn N, Tantilipikorn P, Piboonpocanan O, et al. Alteration of -656(G/T) and -607(C/A) polymorphisms in interleukin-18 (IL-18) gene in house dust mite-sensitive allergic rhinitis patients in Thailand. Genet Mol Res. 2017;16:3.
25.
Zurück zum Zitat Ibrahim GH, Eltabbakh MT, Gomaa AHA, Mohamed EA. Interleukin-18 gene polymorphisms in Egyptian patients with allergic diseases. Am J Rhinol Allergy. 2012;26(5):385–9.PubMed Ibrahim GH, Eltabbakh MT, Gomaa AHA, Mohamed EA. Interleukin-18 gene polymorphisms in Egyptian patients with allergic diseases. Am J Rhinol Allergy. 2012;26(5):385–9.PubMed
26.
Zurück zum Zitat Holla LI, Hrdliková B, Schüller M, Buckova D, Kindlova D, Izakovic V, et al. Haplotype analysis of the interleukin-18 gene in Czech patients with allergic disorders. Human Immunol. 2010;71(6):597. Holla LI, Hrdliková B, Schüller M, Buckova D, Kindlova D, Izakovic V, et al. Haplotype analysis of the interleukin-18 gene in Czech patients with allergic disorders. Human Immunol. 2010;71(6):597.
27.
Zurück zum Zitat Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Euro J Epidemiol. 2010;25(9):603–5. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Euro J Epidemiol. 2010;25(9):603–5.
28.
Zurück zum Zitat Li ZL, Li YG, Lu JP, Chen SQ. Study on FOXP3 -924 polymorphisms in patients with allergic rhinitis. Anat Res. 2014;36(2):124–7. Li ZL, Li YG, Lu JP, Chen SQ. Study on FOXP3 -924 polymorphisms in patients with allergic rhinitis. Anat Res. 2014;36(2):124–7.
29.
Zurück zum Zitat Hassannia H, Abediankenari S, Ghaffari J. FOXP3 and TGFβgene polymorphisms in allergic rhinitis. Iran J Immunol. 2011;8(4):218–25.PubMed Hassannia H, Abediankenari S, Ghaffari J. FOXP3 and TGFβgene polymorphisms in allergic rhinitis. Iran J Immunol. 2011;8(4):218–25.PubMed
30.
Zurück zum Zitat Song QL. Study on the relationship between FOXP3 gene polymorphism and allergic rhinitis. Int J Immunol. 2016;39(2):139–41. Song QL. Study on the relationship between FOXP3 gene polymorphism and allergic rhinitis. Int J Immunol. 2016;39(2):139–41.
31.
Zurück zum Zitat Kim JJ, Min JY, Lee JH. Polymorphisms in the IL-13 and IL-4 receptor alpha genes and allergic rhinitis. Eur Arch Otorhinolaryngol. 2007;264(4):395–9.PubMed Kim JJ, Min JY, Lee JH. Polymorphisms in the IL-13 and IL-4 receptor alpha genes and allergic rhinitis. Eur Arch Otorhinolaryngol. 2007;264(4):395–9.PubMed
32.
Zurück zum Zitat Micheal S, Minhas K, Ishaque M, Ahmed F, Ahmed A. IL-4 gene polymorphisms and their association with atopic asthma and allergic rhinitis in Pakistani patients. J Investig Allergol Clin Immunol. 2013;23(2):107–11.PubMed Micheal S, Minhas K, Ishaque M, Ahmed F, Ahmed A. IL-4 gene polymorphisms and their association with atopic asthma and allergic rhinitis in Pakistani patients. J Investig Allergol Clin Immunol. 2013;23(2):107–11.PubMed
33.
Zurück zum Zitat Li YG, Liu ZW, Lu JP. Investigation into the polymorphism of interleukin-13 1112 C%3eT in allergic rhinitis patients. China Trop Med. 2012;12(1):67–9. Li YG, Liu ZW, Lu JP. Investigation into the polymorphism of interleukin-13 1112 C%3eT in allergic rhinitis patients. China Trop Med. 2012;12(1):67–9.
34.
Zurück zum Zitat Lee HM, Park SA, Chung SW, Woo JS, Chae SW, Lee SH, et al. Interleukin-18/-607 gene polymorphism in allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2006;70(6):1085–8.PubMed Lee HM, Park SA, Chung SW, Woo JS, Chae SW, Lee SH, et al. Interleukin-18/-607 gene polymorphism in allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2006;70(6):1085–8.PubMed
35.
Zurück zum Zitat KleinJan A, Willart M, Van Nimwegen M, Leman K, Hoogsteden HC, Hendriks RW, et al. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. Clin Exp Allergy. 2010;40(3):494–504.PubMed KleinJan A, Willart M, Van Nimwegen M, Leman K, Hoogsteden HC, Hendriks RW, et al. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. Clin Exp Allergy. 2010;40(3):494–504.PubMed
36.
Zurück zum Zitat Ciprandi G. Symptom severity and allergen-specific IgE in allergic rhinitis. Iran J Allergy Asthma Immunol. 2017;16(1):79–81.PubMed Ciprandi G. Symptom severity and allergen-specific IgE in allergic rhinitis. Iran J Allergy Asthma Immunol. 2017;16(1):79–81.PubMed
37.
Zurück zum Zitat Devos FC, Pollaris L, Cremer J, Seys S, Hoshino T, Ceuppens J, et al. IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice. PLoS ONE. 2017;12(7):e0180690.PubMedPubMedCentral Devos FC, Pollaris L, Cremer J, Seys S, Hoshino T, Ceuppens J, et al. IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice. PLoS ONE. 2017;12(7):e0180690.PubMedPubMedCentral
38.
Zurück zum Zitat Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2011;129(1):191.e1–4–8.e1–4. Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2011;129(1):191.e1–4–8.e1–4.
39.
Zurück zum Zitat Yosri H, Elkashef WF, Said E, Gameil NM. Crocin modulates IL-4/IL-13 signaling and ameliorates experimentally induced allergic airway asthma in a murine model. Int Immunopharmacol. 2017;50:305–12.PubMed Yosri H, Elkashef WF, Said E, Gameil NM. Crocin modulates IL-4/IL-13 signaling and ameliorates experimentally induced allergic airway asthma in a murine model. Int Immunopharmacol. 2017;50:305–12.PubMed
40.
Zurück zum Zitat Guo LY, Li JH, Paul WE. Probabilistic regulation in TH2 Cells accounts for monoallelic expression of IL-4 and IL-13. Immunity. 2005;23(1):89–99.PubMed Guo LY, Li JH, Paul WE. Probabilistic regulation in TH2 Cells accounts for monoallelic expression of IL-4 and IL-13. Immunity. 2005;23(1):89–99.PubMed
41.
Zurück zum Zitat Defrance T. Interleukin 13 is a B cell stimulating factor. J Exp Med. 1994;179(1):135–43.PubMed Defrance T. Interleukin 13 is a B cell stimulating factor. J Exp Med. 1994;179(1):135–43.PubMed
42.
Zurück zum Zitat Ngoc PL, Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedón JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol. 2005;5(2):161–6.PubMed Ngoc PL, Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedón JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol. 2005;5(2):161–6.PubMed
43.
Zurück zum Zitat Alasandagutti ML, Ansari MSS, Sagurthi SR, Valluri V, Gaddam S. Role of IL-13 genetic variants in signalling of asthma. Inflammation. 2017;40(2):1–12. Alasandagutti ML, Ansari MSS, Sagurthi SR, Valluri V, Gaddam S. Role of IL-13 genetic variants in signalling of asthma. Inflammation. 2017;40(2):1–12.
44.
Zurück zum Zitat Gleń J, Trzeciak M, Sobjanek M, Bandurski T, Wilkowska A, Nedoszytko B, et al. Interleukin-13 promoter gene polymorphism -1112 C/T is associated with Atopic dermatitis in Polish patients. Acta Dermatovenerol Croat. 2012;20(4):231–8.PubMed Gleń J, Trzeciak M, Sobjanek M, Bandurski T, Wilkowska A, Nedoszytko B, et al. Interleukin-13 promoter gene polymorphism -1112 C/T is associated with Atopic dermatitis in Polish patients. Acta Dermatovenerol Croat. 2012;20(4):231–8.PubMed
45.
Zurück zum Zitat Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen LK, et al. Association between an interleukin-13 promoter polymorphism and atopy. Int J Immunogenet. 2003;30(5):355–9. Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen LK, et al. Association between an interleukin-13 promoter polymorphism and atopy. Int J Immunogenet. 2003;30(5):355–9.
46.
Zurück zum Zitat Ying XJ, Zhao SW, Wang GL, Tzianabos AO, Weiss ST, Celedón JC. Association of interleukin-13 SNP rs20541 with allergic rhinitis risk: a meta-analysis. Gene. 2013;521(2):222–6.PubMed Ying XJ, Zhao SW, Wang GL, Tzianabos AO, Weiss ST, Celedón JC. Association of interleukin-13 SNP rs20541 with allergic rhinitis risk: a meta-analysis. Gene. 2013;521(2):222–6.PubMed
47.
Zurück zum Zitat Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24(1):209–26.PubMed Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24(1):209–26.PubMed
48.
Zurück zum Zitat Wang K, Zhu TJ, Wang HJ, Yang JX, Du SS, Dong GY, et al. Adoptive transfers of CD4+ CD25+ Tregs raise FOXP3 expression and alleviate mouse enteritis. Biomed Res Int. 2018;2018(2):1–9. Wang K, Zhu TJ, Wang HJ, Yang JX, Du SS, Dong GY, et al. Adoptive transfers of CD4+ CD25+ Tregs raise FOXP3 expression and alleviate mouse enteritis. Biomed Res Int. 2018;2018(2):1–9.
49.
Zurück zum Zitat Solomou EE, Rezvani K, Mielke S, Malide D, Visconte V, Keyvanfer K, et al. FOXP3-positive regulatory T-cells in acquired aplastic anemia. Blood. 2006;108(11):2248. Solomou EE, Rezvani K, Mielke S, Malide D, Visconte V, Keyvanfer K, et al. FOXP3-positive regulatory T-cells in acquired aplastic anemia. Blood. 2006;108(11):2248.
50.
Zurück zum Zitat Cui G, Zhang Y, Gong Z, Zhang JZ, Zang YQ. Induction of CD4+CD25+FOXP3+ regulatory T cell response by glatiramer acetate in type 1 diabetes. Cell Res. 2009;19(5):574–83.PubMed Cui G, Zhang Y, Gong Z, Zhang JZ, Zang YQ. Induction of CD4+CD25+FOXP3+ regulatory T cell response by glatiramer acetate in type 1 diabetes. Cell Res. 2009;19(5):574–83.PubMed
51.
Zurück zum Zitat Choi JM, Shin JH, Sohn MH. Cell-permeable FOXP3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci USA. 2010;107(50):21943–21943. Choi JM, Shin JH, Sohn MH. Cell-permeable FOXP3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci USA. 2010;107(50):21943–21943.
52.
Zurück zum Zitat Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol. 2007;148(1):53–63.PubMedPubMedCentral Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol. 2007;148(1):53–63.PubMedPubMedCentral
53.
Zurück zum Zitat Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28(4):201–7.PubMed Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28(4):201–7.PubMed
Metadaten
Titel
The association between IL18, FOXP3 and IL13 genes polymorphisms and risk of allergic rhinitis: a meta-analysis
verfasst von
Liang Tang
Yongjun Chen
Qin Xiang
Ju Xiang
Yonghong Tang
Jianming Li
Publikationsdatum
11.06.2020
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 9/2020
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-020-01368-4

Weitere Artikel der Ausgabe 9/2020

Inflammation Research 9/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.